This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Musc Foundation for Research Development. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Aiping Bai: Innovator in Ceramidase Inhibition
Introduction
Aiping Bai is a prominent inventor based in Charleston, SC (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit acid ceramidase. Her work has implications for treating various diseases, including cancer and inflammation.
Latest Patents
Aiping Bai holds a patent for "Lysosomotropic inhibitors of acid ceramidase." This patent describes compounds that can inhibit acid ceramidase and ceramidase-related activity. The disclosed compounds are formulated to be used as drugs and prodrugs for the treatment and prevention of diseases associated with undesirable ceramidase or sphingosine kinase activity. These diseases include cancer, cancer metastasis, atherosclerosis, stenosis, inflammation, asthma, and atopic dermatitis.
Career Highlights
Aiping Bai is affiliated with the Medical University of South Carolina Foundation for Research Development. Her research focuses on the biochemical pathways involved in ceramide metabolism and its implications for human health. She has been instrumental in advancing the understanding of ceramidase's role in various diseases.
Collaborations
Aiping Bai has collaborated with notable researchers in her field, including Yusuf A Hannun and Liu Xiang. These collaborations have enhanced the depth and breadth of her research, contributing to significant advancements in the understanding of ceramidase inhibition.
Conclusion
Aiping Bai's innovative work in the field of acid ceramidase inhibition showcases her dedication to advancing medical science. Her contributions have the potential to lead to new therapeutic strategies for serious health conditions.